The expiry of the semaglutide patent, the molecule in Novo Nordisk's weight-loss drugs Wegovy and Ozempic, in India in March, has attracted many generics majors to tap one of the fastest-growing segments globally
ADSCs at passage 34 were and resuspended and incubated with the antibodies or isotype
Previous-generation NS3/4A protease inhibitor-containing regimens have been associated with AEs, including severe rash, marked hyperbilirubinemia, neutropenia, anemia, and elevated ALT, particularly in patients with cirrhosis.[26] However, all of these events were absent or rarely observed in SURVEYOR-II Part 3, even in patients with compensated cirrhosis
Avoiding sun exposure by wearing hats and daily sunscreen reduces photo-aging and damage
Nevertheless, they are good news for patients with psychiatric disorders, who are at an increased risk of diabetes. Dr De Giorgi adds that while semaglutide is also used in people with obesity, with some diabetes patients also presenting with a higher weight, the findings from this study cannot be applied to people who do not have diabetes.
